Diagnostic Products Corporation Announces Quarterly Dividend
April 14 2006 - 8:00AM
Business Wire
Diagnostic Products Corporation (NYSE:DP) announced today the
declaration of a quarterly cash dividend of $.07 per share of
Common Stock payable May 16, 2006 to shareholders of record on
April 28, 2006. Diagnostic Products Corporation, founded in 1971,
is a leader in the global in vitro diagnostics market. DPC's
product offering includes the widely accepted IMMULITE(R) series of
immunoassay systems, more than 75 immunoassays and an expanding
menu of essential specific allergens and allergy panels that are
run just like other immunoassays. DPC also designs and manufactures
automated laboratory instrumentation and automation solutions that
provide fast, accurate results while enabling our customers to do
"more with less" in a leaner laboratory. DPC's combined chemistry
and immunoassay menu is one of the largest and most diversified
available, covering most laboratory tests requested. DPC sells its
products to hospitals, clinics and laboratories in more than 100
countries. Additional Company information can be found on DPC's
website at www.dpcweb.com.
Diagnostic Products (NYSE:DP)
Historical Stock Chart
From May 2024 to Jun 2024
Diagnostic Products (NYSE:DP)
Historical Stock Chart
From Jun 2023 to Jun 2024